NASDAQ:MDGL - Madrigal Pharmaceuticals, Inc.
$89.07
 $-2.74
-2.98%
4:00PM EDT
2019-07-22
Madrigal Pharmaceuticals, Inc., formerly Synta Pharmaceuticals Corp., is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH). The Company's lead product, MGL-3196, is a Phase II-ready once-daily, oral, liver-directed selective thyroid hormone receptor-b (THR-b) agonist for the treatment of NASH, and heterozygous and homozygous familial hypercholesterolemia (FH). Its product pipeline also includes MGL-3745, which is used in the treatment of NASH and FH. MGL-3196 has completed Phase I single and multiple dose trials in healthy volunteers. MGL-3196 is being developed for dyslipidemia/hypercholesterolemia to lower low-density lipoproteins cholesterol, triglyceride levels and lipoprotein(a). MGL-3196 also reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MDGL     avg for
industry  
  avg for
sector  
42 stocks weight:  47. 04   217. 37   399. 45  
42 stocks rank:  2. 44 K 1. 27 K 716. 99  
# analyst opinions:  12. 00   13. 21   13. 71  
mean recommendation:  2. 20   2. 10   2. 04  

quick ratio:  45. 70   5. 49   1. 88  
current ratio:  45. 75   5. 87   2. 36  

target price low:  126. 00   83. 44   114. 90  
target price avg:  205. 67   106. 20   137. 90  
target price high:  124. 78   132. 30   158. 97  
1-yr high:  284. 40   111. 86   142. 57  
last close:  91. 81   86. 79   125. 44  
50-day avg:  99. 86   86. 68   122. 63  
200-day avg:  126. 36   89. 22   121. 38  
1-yr low:  91. 13   69. 78   100. 51  
volume:  134. 59 K 2. 62 M 3. 43 M
50-day avg volume:  160. 28 K 3. 20 M 4. 16 M
200-day avg volume:  231. 64 K 2. 99 M 4. 75 M

1-day return:  -3. 60 % -1. 30 % -0. 99 %
this week return:  -9. 13 % 0. 45 % -0. 20 %
12-wk return:  -16. 94 % 0. 94 % 4. 84 %
52-wk return:  -66. 51 % -1. 30 % 10. 55 %

enterprise value (EV):  938. 64 M 45. 10 B 122. 38 B
market cap:  1. 42 B 38. 96 B 108. 40 B
EBITDA:  -51. 63 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -18. 18   5. 38   11. 93  
total debt:  900. 00 K 10. 90 B 17. 48 B
debt/equity:  0. 19   57. 18   120. 05  
net income (common):  -41. 53 M 2. 07 B 4. 05 B

shares outstanding:  14. 25 M 538. 09 M 1. 24 B
shares:  6. 41 M 548. 00 M 1. 22 B
shares short:  2. 48 M 10. 98 M 11. 87 M
shares short prior month:  2. 09 M 9. 32 M 12. 05 M
short ratio:  13. 16   5. 60   3. 34  
short % of float:  36. 49 % 6. 48 % 2. 64 %
total cash/share:  30. 99   10. 98   9. 19  
total cash:  477. 82 M 5. 93 B 6. 10 B
free cash flow:  -10. 28 M 2. 92 B 4. 55 B
operating cash flow:  -23. 34 M 3. 80 B 5. 78 B

book value:  30. 39   13. 35   27. 45  
price/book:  3. 02   4. 60   8. 78  
operating margins:  0. 00 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -2. 75   2. 10   4. 23  
forward EPS:  -6. 95   3. 45   7. 10  
P/E:  -33. 40   1. 90   32. 10  
forward P/E:  -13. 21   6. 46   15. 47  
PE/G:  27. 16   0. 70   -0. 54  
growth:  -1. 23 % 265. 63 % 79. 11 %
earnings high:  -1. -1   0. 89   1. 68  
earnings avg:  -1. 19   0. 70   1. 57  
earnings low:  -1. 67   0. 46   1. 46  
revenue high:  -0. 00   2. 57 B 11. 07 B
revenue avg:  -0. 00   2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -9. 75 % -2. 34 % 5. 28 %
return on equity:  -12. 86 % -90. 08 % 133. 53 %

beta (1yr vs S&P500):  2. 03   1. 27   0. 91  
sharpe (1yr):  -1. 51   0. 16   0. 77  

held % insiders:  11. 33 % 6. 06 % 3. 29 %
held % institutions:  97. 08 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : MDGL
.    145.319 =       145.319 :: --> INITIAL WEIGHT <--
.    - 2.749 =        142.57 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.719 =       387.627 :: P/E factor
.    x 0.796 =       308.473 :: PE/G factor
.    x 1.468 =        452.73 :: beta factor
.    x 0.796 =       360.456 :: sharpe factor
.    x 5.576 =      2009.864 :: current ratio factor
.    x 1.011 =      2032.222 :: quick ratio factor
.    x 1.037 =       2108.02 :: short ratio factor
.    x 1.031 =      2174.243 :: price-to-book factor
.    x 1.002 =       2177.89 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =      4618.854 :: sector+industry 1-year gains factor
.    x 1.009 =      4662.401 :: industry 12-weeks return factor
.    x 1.308 =      6097.901 :: industry 2-weeks return factor
.    x 0.847 =      5166.439 :: company one-year gains+dividend factor
.    x 0.953 =      4923.786 :: company 13 weeks' performance factor
.     x 0.98 =      4826.747 :: "drift" penalty 3 days ago
.    x 0.979 =      4724.444 :: "drift" penalty 5 days ago
.    / 1.981 =      2385.225 :: overall "drift" factor
.    x 0.911 =      2173.579 :: largest single-day jump factor
.        x 1 =      2173.579 :: volatility factor
.        x 1 =      2173.579 :: 42-day volatility factor
.    x 2.485 =       5402.37 :: notable returns + performance factor
.    x 3.541 =     19130.389 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.539 =     10320.761 :: forward EPS factor
.    x 0.833 =      8593.703 :: forward P/E factor
.    x 1.185 =     10181.068 :: industry recommendation factor
.    x 1.932 =      19665.94 :: company recommendation factor
.    x 1.003 =     19720.324 :: factor historical industry gain for week 29
.   x 10.733 =    211655.555 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        21.449 :: reduced for readability
.   + 25.595 =        47.044 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     47.044 :: FINAL WEIGHT for NASDAQ:MDGL


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org